Mitsutoshi Nakamura Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

3/2019

Expression of peptide transporter 1 has a positive correlation in protoporphyrin IX accumulation induced by 5-aminolevulinic acid with photodynamic detection of non-small cell lung cancer and metastatic brain tumor specimens originating from non-small cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitsutoshi Nakamura Research Topics

Disease

40	Neoplasms (Cancer) 03/2024 - 04/2002
16	Prostatic Neoplasms (Prostate Cancer) 07/2009 - 10/2002
13	Glioblastoma (Glioblastoma Multiforme) 02/2024 - 02/2005
9	Wounds and Injuries (Trauma) 05/2024 - 12/2017
8	Carcinoma (Carcinomatosis) 01/2010 - 04/2002
5	Carcinogenesis 07/2008 - 04/2002
4	Glioma (Gliomas) 08/2022 - 07/2009
4	Infarction (Infarctions) 01/2013 - 06/2006
4	Ischemia 05/2011 - 03/2007
4	Spinal Cord Ischemia 01/2008 - 04/2003
3	Brain Neoplasms (Brain Tumor) 02/2024 - 01/2014
3	Cicatrix (Scar) 01/2023 - 01/2018
3	Inflammation (Inflammations) 10/2019 - 01/2007
3	Meningioma (Meningiomas) 08/2019 - 01/2011
3	Hypotension (Low Blood Pressure) 04/2010 - 03/2005
3	Oligodendroglioma 07/2009 - 03/2002
3	Astrocytoma (Pilocytic Astrocytoma) 02/2005 - 03/2002
2	Wiskott-Aldrich Syndrome 01/2023 - 01/2018
2	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2006
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 08/2022 - 10/2019
2	Necrosis 06/2020 - 01/2016
2	Neoplasm Metastasis (Metastasis) 01/2014 - 02/2009
2	Carcinoma in Situ 01/2010 - 04/2009
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2010 - 04/2009
2	Lymphatic Metastasis 01/2007 - 07/2005
2	Squamous Cell Carcinoma of Head and Neck 07/2005 - 07/2003
1	Noninfiltrating Intraductal Carcinoma (DCIS) 08/2023
1	Colorectal Neoplasms (Colorectal Cancer) 10/2022

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 12/2023 - 03/2002
6	ActomyosinIBA 05/2024 - 01/2020
6	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2008 - 04/2002
5	Small Interfering RNA (siRNA)IBA 01/2010 - 01/2008
5	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2008 - 04/2002
4	LigandsIBA 02/2024 - 01/2019
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 04/2002
4	Phosphotransferases (Kinase)IBA 04/2009 - 06/2003
4	Messenger RNA (mRNA)IBA 01/2008 - 02/2003
3	Temozolomide (Temodar)FDA LinkGeneric 02/2024 - 07/2012
3	AntigensIBA 10/2022 - 10/2006
3	epidermal growth factor receptor VIIIIBA 06/2020 - 09/2018
3	Cadherins (E-Cadherin)IBA 01/2014 - 04/2002
3	Neuroprotective AgentsIBA 05/2011 - 08/2009
3	Isoflurane FDA LinkGeneric 04/2010 - 03/2005
3	Hormones (Hormone)IBA 07/2009 - 01/2006
3	AndrogensIBA 07/2009 - 03/2003
2	SeptinsIBA 05/2024 - 11/2023
2	AnnexinsIBA 12/2023 - 12/2017
2	InterferonsIBA 08/2023 - 06/2020
2	GTP Phosphohydrolases (GTPases)IBA 01/2023 - 12/2017
2	Myosins (Myosin)IBA 01/2023 - 12/2017
2	Carmustine (FIVB)FDA Link 08/2022 - 08/2015
2	Interleukin-2 (IL2)IBA 09/2021 - 06/2020
2	Chimeric Antigen ReceptorsIBA 06/2020 - 09/2018
2	ErbB Receptors (EGF Receptor)IBA 06/2020 - 09/2018
2	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2020 - 12/2017
2	Peptides (Polypeptides)IBA 03/2019 - 09/2007
2	Thomsen-Friedenreich antibodiesIBA 01/2016 - 01/2014
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 10/2011 - 05/2011
2	deoxyuridine triphosphateIBA 10/2011 - 05/2011
2	Syndecan-1 (Syndecan 1)IBA 01/2010 - 07/2009
2	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2010 - 07/2009
2	VimentinIBA 04/2009 - 01/2007
2	Nerve Growth Factors (Neurotrophins)IBA 01/2009 - 01/2009
2	4- (alpha- (4- allyl- 2,5- dimethyl- 1- piperazinyl)- 3- methoxybenzyl)- N,N- diethylbenzamideIBA 01/2008 - 07/2004
2	Opioid Analgesics (Opioids)IBA 01/2008 - 07/2004
2	matrigelIBA 01/2008 - 09/2007
2	salicylhydroxamic acid (SHAM)IBA 10/2007 - 04/2003
2	Mitogen-Activated Protein KinasesIBA 09/2007 - 11/2002
2	DNA (Deoxyribonucleic Acid)IBA 01/2007 - 07/2002
2	Serine (L-Serine)FDA Link 01/2006 - 08/2005
2	Estrogens (Estrogen)FDA Link 01/2006 - 06/2003
2	AntibodiesIBA 12/2004 - 07/2003
2	Prostate-Specific Antigen (Semenogelase)IBA 12/2004 - 07/2003
2	2-MethoxyestradiolIBA 01/2004 - 06/2003
2	Death Domain ReceptorsIBA 01/2004 - 06/2003
2	Etoposide (VP 16)FDA LinkGeneric 06/2003 - 10/2002
2	FenretinideIBA 03/2003 - 11/2002
1	Chemokine ReceptorsIBA 02/2024
1	ChemokinesIBA 02/2024
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2023
1	CalciumIBA 12/2023
1	CytokinesIBA 09/2023
1	CRISPR-Cas Systems Guide RNAIBA 08/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2023
1	CRISPR-Associated Protein 9IBA 08/2023
1	Actins (F Actin)IBA 01/2023
1	3- (2- iodoacetamido)- 2,2,5,5- tetramethyl- 1- pyrrolidinyloxyl (IPSL)IBA 10/2022
1	HLA-A*33 antigenIBA 10/2022
1	Cancer VaccinesIBA 10/2022
1	EnzymesIBA 10/2022
1	Insulin (Novolin)FDA Link 12/2020
1	Profilins (Profilin)IBA 12/2020

Therapy/Procedure

8	Therapeutics 07/2012 - 08/2005
7	Immunotherapy 03/2024 - 01/2014
3	Radiotherapy 02/2024 - 01/2011
3	Drug Therapy (Chemotherapy) 07/2009 - 03/2002
2	Anesthesia 04/2010 - 03/2007
2	Transplantation 01/2009 - 01/2009
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2009 - 01/2009
1	Hematopoietic Stem Cell Transplantation 08/2022